Li et al., 2000 - Google Patents
Recombinant subunit ORF2. 1 antigen and induction of antibody against immunodominant epitopes in the hepatitis E virus capsid proteinLi et al., 2000
View PDF- Document ID
- 14614936621735320625
- Author
- Li F
- Riddell M
- Seow H
- Takeda N
- Miyamura T
- Anderson D
- Publication year
- Publication venue
- Journal of medical virology
External Links
Snippet
A recombinant subunit antigen (ORF2. 1), representing the carboxy-terminal 267 amino acids of the 660-amino-acid hepatitis E virus (HEV) capsid protein, was expressed in Escherichia coli and used for the immunisation of rats. Purified antigen formulated with …
- 241000724675 Hepatitis E virus 0 title abstract description 70
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/295—Polyvalent viral antigens; Mixtures of viral and bacterial antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/70—Multivalent vaccine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55505—Inorganic adjuvants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
- C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses, e.g. hepatitis E virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Li et al. | Recombinant subunit ORF2. 1 antigen and induction of antibody against immunodominant epitopes in the hepatitis E virus capsid protein | |
| Meng et al. | Identification and characterization of the neutralization epitope (s) of the hepatitis E virus | |
| Guo et al. | Foot-and-mouth disease virus-like particles produced by a SUMO fusion protein system in Escherichia coli induce potent protective immune responses in guinea pigs, swine and cattle | |
| Elgh et al. | A major antigenic domain for the human humoral response to Puumala virus nucleocapsid protein is located at the aminoterminus | |
| TW202207979A (en) | Combination vaccine | |
| KR101121754B1 (en) | The polypeptide fragments of hepatitis e virus, the vaccine composition comprising said fragments and the diagnostic kits | |
| US20020018780A1 (en) | Epitope-based vaccine for respiratory syncytial virus F-protein | |
| JP4463877B2 (en) | Synthetic peptides and vaccines containing them | |
| EP4410843A1 (en) | Recombinant fusion protein derived from hr region of s2 protein of sars-cov-2 and application of recombinant fusion protein | |
| CN113801207B (en) | Novel coronavirus tandem epitope polypeptide vaccine and application thereof | |
| JP2007537137A (en) | Norovirus monoclonal antibody and peptide | |
| Koletzki et al. | Puumala (PUU) hantavirus strain differences and insertion positions in the hepatitis B virus core antigen influence B-cell immunogenicity and protective potential of core-derived particles | |
| US6174532B1 (en) | L2 immunogenic peptides of papillomavirus | |
| US20210292372A1 (en) | Compositions and methods for treating, including preventing, parvovirus infections and related diseases | |
| Liu et al. | Quadruple antigenic epitope peptide producing immune protection against classical swine fever virus | |
| US20150202282A1 (en) | Pcv2 orf2 virus like particle with foreign amino acid insertion | |
| KR100743580B1 (en) | Novel hev antigenic peptide and methods | |
| WO2007010291A1 (en) | Vaccine | |
| JP4053587B2 (en) | Inactivated respiratory synthetic virus vaccine | |
| Yi et al. | Recombinant bivalent vaccine against foot-and-mouth disease virus serotype O/A infection in guinea pig | |
| CN105085671B (en) | Monoclonal immunoglobulin G antibodies against enterovirus 3D proteins and immunogenic compositions thereof | |
| US7595053B2 (en) | Chimeric T helper-B cell peptide vaccine for Japanese encephalitis virus | |
| JP2008127283A (en) | Vaccine for feline infectious peritonitis | |
| Murdin | Studies of Aphthovirus Subunits and Synthetic Peptides Relevant to Their Use as Vaccines Against Foot and Mouth Disease | |
| AU5013099A (en) | Papillomavirus vaccine |